|
maps • volume xv number 1 • Spring 2005
|
Why I Support the Pill Testing Program
(and why you should, too)
By Adam Wiggins
|
|
At the end of 2003, one of the most innovative and important harm-reduction programs ever
implemented stopped running. Not for lack of interest, or lack of need; but for the lack of funds. It was
a terrible shame that this program, which has educated millions and perhaps even saved lives, should
end so abruptly when it was needed most.
Now it's about to happen all over again.
Sometime in 2005, the funds I provided to bring the pill testing program back online will run out;
and I will not be able to replenish them myself. In order for this wonderful and important program to
continue, we need your help.
For those of you not already familiar with it: this program allows people to send pills to a laboratory
for testing, with the results posted anonymously to ecstasydata.org. Knowing what drug(s) their pill
contains gives them an accurate picture of the risks they will face if they do choose to take it.
Why did I decide to step in and help the program one year ago? I'm not a wealthy philanthropist, as
you might think. My income does not qualify me for anything better than middle-class. I chose to tap
into some of my savings and my disposable income for the year; forgo a few luxuries and improvements
to my home. Instead I did something good for the world, something I can be proud of forever.
If you're reading this, you probably take for granted the importance of the testing program. But
perhaps in taking it for granted, you've forgotten just how important it really is.
To date, medical science has primarily focused on fixing things when they are broken. Infections,
broken bones, specific infectious diseases--conventional medicine is astonishingly advanced in these
areas. What has been neglected, however, is overall health and well-being. Any medical practitioner
will tell you that, even in this advanced age of science, most of what they do is try to help our bodies
heal themselves. And our bodies do this best when we are happy, health, and spiritually fulfilled.
MDMA has such an obvious general-purpose application to this realm that it is difficult to believe
that it has been so overlooked by medical science and the general public. The problem, of course, is
that research is difficult or impossible, and MDMA's black market status means that the effectiveness
and safety of the pills that an individual can acquire are highly variable. This results in many bad
experiences, injury, or even very occasionally, death.
The pill testing program gives people the knowledge they need to get real MDMA of reasonable
quality. This not only saves lives, but allows people to experience the health benefits of this medicine
properly. It provides a buffer against the uncertainty of the black market.
According to the DEA, over 100 million doses of MDMA are consumed in the US each year. The
true number is probably much higher. In other words, the danger of the black market stops few, if
any, people from using MDMA. The DanceSafe/MAPS/Erowid pill testing program arms millions of
Americans, and many more worldwide, with the knowledge they need to keep themselves safe.
But now this program is about to disappear again. The amount of money it needs to keep going for
another year is about $18,000: a paltry sum compared to the immense good it will do in that time.
You're not a wealthly philanthropist, but neither was I. You don't have to be. Just 500 people
contributing $30 each will save this program!
|
| |
| Summer 2008 |
Vol. 18, No. 2 |
Phoenix Rising: A Review of MAPS Research |
| Winter 2008 |
Vol. 18, No. 1 |
Special Edition: Technology and Psychedelics |
| Winter 2007 |
Vol. 17, No. 3 |
MAPS 06-07 Fiscal Yearly Report |
| Autumn 2007 |
Vol. 17, No. 2 |
Special Edition: Psychedelics and Self-Discovery |
| Spring/Summer 2007 |
Vol. 17, No. 1 |
The Chrysalis Stage |
| Winter 2006-7 |
Vol. 16, No. 3 |
Low Maintenance/High Performance |
| Autumn 2006 |
Vol. 16, No. 2 |
Technologies of Healing |
| Spring 2006 |
Vol. 16, No. 1 |
MAPS' 20th Anniversary |
| Winter 2005 |
Vol. 15, No. 3 |
MAPS final year as a teenager |
| Summer 2005 |
Vol. 15, No. 2 |
Israel Conference: MDMA/PTSD Research |
| Spring 2005 |
Vol. 15, No. 1 |
Accelerating flow of work and time |
| Autumn 2004 |
Vol. 14, No. 2 |
Rites of Passage: Kids and Psychedelics |
| Summer 2004 |
Vol. 14, No. 1 |
10 stamps and $250,000 |
| Winter 2003 |
Vol. 13, No. 2 |
Holy Fire |
| Spring 2003 |
Vol. 13, No. 1 |
60th Anniversary of the Discovery
of LSD |
| Autumn 2002 |
Vol. 12, No. 3 |
Vision |
| Summer 2002 |
Vol. 12, No. 2 |
"From celebration to frustration,
and back again." |
| Spring 2002 |
Vol. 12, No. 1 |
Sex, Spirit & Psychedelics 2002 |
| Autumn 2001 |
Vol. 11, No. 2 |
"In the future, it will be called
Despair." |
| Spring 2001 |
Vol. 11, No. 1 |
"A Tidal Wave of Ecstasy!" |
| Autumn 2000 |
Vol. 10, No. 3 |
Creativity 2000 |
| Summer 2000 |
Vol. 10, No. 2 |
Endings and Beginnings |
| Spring 2000 |
Vol. 10, No. 1 |
Making History in Slow Motion |
| Winter 1999/00 |
Vol. 9, No. 4 |
To the Ends of the Earth for MDMA
Research... |
| Autumn 1999 |
Vol. 9, No. 3 |
MAPS' long-standing efforts to conduct... |
| Summer 1999 |
Vol. 9, No. 2 |
MAPS has come full circle... |
| Spring 1999 |
Vol. 9, No. 1 |
Patience, persistence and passion |
| Winter 1998/99 |
Vol. 8, No. 4 |
One of special pleasures of directing
MAPS... |
| Autumn 1998 |
Vol. 8, No. 3 |
The Ayahuasca Issue (with Hofmann
interview) |
| Summer 1998 |
Vol. 8, No. 2 |
Emotionally Powerful Anecdotes... |
| Spring 1998 |
Vol. 8, No. 1 |
Death Has a Way of Focusing One's
Attention |
| Autumn 1997 |
Vol. 7, No. 4 |
Celebration is in Order |
| Summer 1997 |
Vol. 7, No. 3 |
Time Horizons |
| Spring 1997 |
Vol. 7, No. 2 |
Synchronicity |
| Winter 1996/97 |
Vol. 7, No. 1 |
Learning to Crawl |
| Autumn 1996 |
Vol. 6, No. 4 |
An Invitation for Dialogue |
| Summer 1996 |
Vol. 6, No. 3 |
Budding Research |
| New Year 1996 |
Vol. 6, No. 2 |
Sending Down Roots |
| Autumn 1995 |
Vol. 6, No. 1 |
Baby Steps |
| Summer 1995 |
Vol. 5, No. 4 |
Opportunity Amidst Obstacles |
| Winter 1994/95 |
Vol. 5, No. 3 |
Clinical Trials and Tribulations |
| Autumn 1994 |
Vol. 5, No. 2 |
Building Towards Clinical Trials |
| Summer 1994 |
Vol. 5, No. 1 |
Politics and Protocols: In Search
of a Balance |
| Spring 1994 |
Vol. 4, No. 4 |
Laying the Groundwork |
| Winter 1993/94 |
Vol. 4, No. 3 |
A Time of Tests |
| Summer 1993 |
Vol. 4, No. 2 |
So Close Yet So Far |
| Spring 1993 |
Vol. 4, No. 1 |
Remembrance and Renewal |
| Winter 1992/93 |
Vol. 3, No. 4 |
Forging New Alliances |
| Summer 1992 |
Vol. 3, No. 3 |
Building on Common Ground |
| Spring 1992 |
Vol. 3, No. 2 |
Small Steps, Gradual Progress, New
Opportunities |
| Winter 1991/92 |
Vol. 3, No. 1 |
The Rekindling of a Thousand Points
of Light |
| Summer 1991 |
Vol. 2, No. 2 |
MDMA protocol development with cancer patients |
| Winter 1990/91 |
Vol. 2, No. 1 |
MAPS' Swiss pharmacologically-assisted psychotherapy
conference |
| Autumn 1990 |
Vol. 1, No. 3 |
What and Who is MAPS? |
| Summer 1989 |
Vol. 1, No. 2 |
Switzerland Leads the Way |
| Summer 1988 |
Vol. 1, No. 1 |
MDMA can become a legal medicine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|